Marc Michaël Bransten

Title: Marc Michaël Bransten: Innovator in Chronic Pathology Diagnostics

Introduction

Marc Michaël Bransten is a notable inventor based in Vincennes, France. He has made significant contributions to the field of medical diagnostics, particularly in relation to chronic pathologies such as Lyme disease. His innovative work has the potential to improve the diagnosis and treatment of these conditions.

Latest Patents

Marc Michaël Bransten holds a patent for the diagnostic and treatment of chronic pathologies, specifically targeting Lyme disease. The invention focuses on several biomarkers, including IL-1RA, IFN-γ, and GM-CSF. These biomarkers' expressions at both the mRNA and protein levels correlate with chronic pathologies, particularly the late chronic form of Lyme disease. The patent provides methods and kits for diagnosing such chronic conditions and assessing a patient's response to treatment. Additionally, it includes methods and therapeutic agents for treating these chronic pathologies.

Career Highlights

Throughout his career, Marc Michaël Bransten has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Marc has collaborated with notable colleagues, including Hugues Gascan and Sylvie Chevalier. Their joint efforts have further advanced the research and development of diagnostic methods for chronic diseases.

Conclusion

Marc Michaël Bransten's contributions to the field of chronic pathology diagnostics highlight his innovative spirit and dedication to improving patient care. His work continues to pave the way for advancements in medical diagnostics and treatment options.